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AIM:  
To elicit clinical advantages of sparing of swallowing structures, 
the pharyngeal constrictors (PC), glottic and supra-glottic larynx (GSL) 
and the esophagus. The primary end point of this study was to analyze 
dysphagia in patients treated with modified IMRT strategy and the 
secondary end point was to compare incidence and severity of dysphagia 
in a retrospective study where the same structures were not spared. 
 
MATERIAL AND METHODS:  
This is a prospective longitudinal study. The period of study was 
May 2013 to May 2014. A total of 26 patients, aged 16 to 70yrs being 
treated with concurrent chemo-radiation with cisplatin for 
nasopharyngeal and oropharyngeal carcinoma (Stage I-IV) with histology 
of SCC and NPC were considered for this study. The IMRT strategy used 
was optimized to spare the PC, GSL, and esophagus with a constraint to 
reduce the volume of these structures receiving more than 50Gy. The 
dose-effect relationship of these structures compared to clinical 
presentation was assessed. The clinical assessment of patients was done 
both subjectively with the help of the HNQOL instrument and objectively 
using penetration and aspiration score (PAS) in modified barium 
swallow.  
The clinical benefit of such a IMRT strategy was analyzed and 
compared to a retrospective group of patients in who the same 
swallowing structures were not given any dose constraints. 
 
RESULTS: 
 Significant correlations were observed between barium swallow 
based dysphagia and the mean doses to the PC, GSL and Esophagus, 
as well as the partial volumes of these structures receiving 50–60 Gy; 
the highest correlations were associated with doses to the superior PC 
(p = 0.001). Significantly worse dysphagia was found post treatment 
(Pre vs Post – 34% vs 27%) 73% of the patients had no dysphagia and 
3 (7.6%) of the patients were gastric tube dependent (1with   
aspiration). Compared to standard IMRT strategy – incidence of 
dysphagia significantly decreased (7.6% compared to 18%).  
 
CONCLUSION: 
 These dose–volume-effect relationships provide initial IMRT 
optimization goals and motivate further efforts to reduce swallowing 
structures doses to reduce dysphagia and aspiration. When compared 
patients in whom the structures were not spared, there was a significant 
improvement in dysphagia. 
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  INTRODUCTION	  
 
In the recent past, therapy for head-and-neck cancer has changed 
dramatically resulting in more intense treatment regimens. The 
intensification of treatment has resulted in improved loco-regional control 
rates and survival, but resulted in severe acute and late toxicities among 
which dysphagia stands out.  
Swallowing is a programmed motor behavior, which occurs within 
seconds and around 600 to 1000 times a day and takes not more than 20 
seconds each time (1). It requires stimulation of sensory nerves in the 
oropharynx. In this phenomenon there is a requirement of precise co-
ordination of more than thirty muscles and six cranial nerves, with 
actions, which are both involuntary and voluntary (2). Swallowing has 
two important features: passage of the food from the oral cavity to the 
stomach and the protection of the airway, which if impaired may lead to 
aspiration. It becomes an important factor depicting the quality of life of 
patients with head and neck cancers. Functional or structural defects of 
the oral cavity, pharynx, larynx and esophagus may lead to dysphagia. 
Dysphagia rehabilitation includes identifying and treating abnormalities 
of feeding and swallowing and also maintaining safe and efficient 
digestion and hydration. For the evaluation and treatment of defects and 
disorders of eating and swallowing, understanding the pathophysiology 
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and physiology is essential. 
1.1 ANATOMY:  
  Structures involved in swallowing are: 
• Oral tongue 
• Faucial pillars 
• Base of tongue 
• Epiglottis 
• Pharyngeal Constrictors 
• Supraglottic and glottic larynx 
• Esophagus 
 
The tongue has consists of two surfaces i.e., both oral and 
pharyngeal surfaces. The faucial pillars separate the oral cavity from 
pharynx. The constrictor muscles of the pharynx originate from the 
thyroid cartilage anteriorly and the hyoid bone and cranium posteriorly 
and insert into the posterior median raphe. Similarly the origin of the sub 
mental muscles is from the mandible and they are attached to the tongue 
and hyoid bone. It is attached to the hyoid bone anteriorly. Anteriorly the 
sides of the cricoid cartilage attaches to the cricopharyngeus muscle. The 
cricopharyngeus muscle facilitates the closure of the upper esophageal 
sphincter by compressing in into the back of the cricoid cartilage. The 
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larynx gives rise to the epiglottis, which is angled upward and backward 
and inserts into the hyoid bone anteriorly. The vallecula is a space 
between the epiglottis and pharyngeal surface of the tongue. The 
laryngeal surface of epiglottis along with the true and false vocal cords 
together forms the larynx. The upper end of the larynx continues into the 
lower portion of the pharynx.  Pyriform recesses are spaces in the 
pharynx which are present on either side of the larynx, lateral to it. 
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Innervation of major muscles related to swallowing 
Cranial Nerves Muscles 
Trigeminal Nerve (V) Tensor Veli Palitini 
Mylohyoid 
Masticatory muscles  
Anterior belly of digastrics 
 
Facial Nerve (VII) Facial muscle 
Stylohyoid  
Posterior belly of digastrics 
Glossopharyngeal Nerve (IX) Stylopharyngeous 
Vagus Nerve (X) Levator levi palitini 
Palatopharyngeous 
Salpingopharyngeous 
Instrinsic laryngeal muscles 
Cricopharyngeus 
Pharyngeal constrictors 
 
Hypoglossal Nerve (XII) Intrinsic tongue muscles 
Hyoglossus 
Genioglossus 
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Styloglossus 
Geniohyoid 
Thyrohyoid 
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1.1 Development of Anatomy: 
There is a difference in anatomy of the head and neck in both 
infants and adults. In the infant, there is no eruption of teeth, there is a 
flatter hard palate and the larynx and hyoid are placed up higher in the 
neck to the oral cavity. The epiglottis contacts the soft palate posteriorly 
so that the larynx is open to the Nasopharynx. A soft tissue barrier 
separates the airway from the oral cavity. However, with development 
there are some anatomical changes seen in the pharynx in adult humans. 
The larynx descends to a lower position in the neck during growth. There 
is no contact of the soft palate with the epiglottis, thus making the 
pharynx longer vertically. The development of speech is thus contributed 
by this change in human development. We become vulnerable for 
aspiration as pharynx becomes a part of both the food way and the 
airway.  
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A) The tongue and palate are flatter and the oral cavity is small in the human infant. 
The epiglottis is nearly attached to the soft palate. Only during swallowing the air way 
and food way are separated B) the larynx is lower in the neck, and the food way and 
airway cross over in the pharynx in an adult. 
 
1.2 PHYSIOLOGY:  
Swallowing is described as the transportation of a food bolus or 
liquid bolus from the oral cavity to the stomach through the pharynx and 
esophagus. A smooth coordinated process, which involves a complex 
series of both voluntary and involuntary neuromuscular contractions, 
constitutes ‘normal deglutition’. This complex involuntary and voluntary 
neuromuscular process involves higher brain centers like tract of nucleus 
solitarius, nucleus ambiguous along with the cranial nerves V, VII, IX, X, 
and XII. There are two models, which were earlier described to study the 
normal physiology of eating and swallowing: 
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• Four Stage Model for drinking and swallowing liquids 
• Process Model for eating solid food.  
 
However a three-stage sequential model was used to describe normal 
swallow in human beings. Based on location of the bolus the swallowing 
process was classified into three phases (3,4):  
• Oral phase 
• Pharyngeal phase 
• Esophageal phase 
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Subsequently the Four Stage Model was introduced by sub-
dividing the oral phase into oral preparatory and oral propulsive phases. 
This Four Stage Model was used to adequately describe the process and 
movement of a liquid bolus through the swallowing process but could not 
account for the movement and swallowing of a solid bolus. Therefore, the 
Process Model of Feeding was introduced to describe the swallowing of a 
solid bolus (5,6). 
 
ORAL PHASE: 
Contraction of muscles of tongue and striated muscles of mastication 
 
 
Bolus is first positioned in the middle of tongue, on the dorsal surface 
 
 
Bolus is pressed firmly against the tonsillar pillars 
 
 
Sensory neurons are trigerred 
 
 
Begins the pharyngeal phase 
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The first phase of swallowing is controlled by the motor nuclei of 
the trigeminal, facial and hyoglossal cranial nerves. This is also the 
involuntary part of this phase. The oral phase is further subdivided into: 
 
• Oral preparatory phase 
• Oral propulsive phase 
 
Oral preparatory phase: This phase basically involves making the bolus 
swallow able. 
Liquid bolus taken into the mouth through cup/straw 
 
 
Bolus held in the anterior part of floor of mouth or on the tongue surface 
against hard palate 
 
 
Simultaneously the oral cavity is sealed by the contact of the soft palate 
and tongue posteriorly – prevents leakage into the oro-pharynx 
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Oral propulsive phase  
The tip of tongue elevates to touch the alveolar ridge of hard palate 
 
 
Simultaneously the posterior tongue drops to allow the bolus into oro-
pharynx 
 
The liquid bolus is squeezed into the pharynx when the tongue 
surface moves upwards expanding the area of tongue and palate contact 
from anterior to posterior. In case of a liquid bolus the pharyngeal phase 
begins during the oral propulsive phase. 
 
Oral Stage for Solid Food (Process Model of Feeding) : 
The process of normal eating in humans, especially food transport 
and bolus formation in the oropharynx could not be described adequately 
by the Four Stage Sequential Model (3-6). The bolus is formed in the 
oropharynx when chewed and moistened food passes through the tonsillar 
fauces in a healthy subject eating solid food. The pharyngeal stage of 
swallowing happens several seconds after this stage of swallowing. While 
the chewing continues in the oral cavity, the food can pass into the 
oropharynx and accumulate there. The events described in the Process 
Model were first observed in mammalian studies (8) and later applied in 
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humans (5). The same does not stand good for the Four Stage Model, as 
there is an overlap of the oral preparatory, propulsive and pharyngeal 
phases. 
1) Stage I transport - When food is ingested into the mouth, the tongue 
carries out three steps: 
• The food is taken to the post-canine region  
• Rotates laterally, 
• Places the food onto the occlusal surface of 
lower teeth for food processing. 
 
2) Food processing – Stage transport is immediately followed by food 
processing. This stage involves making the consistency of bolus ideal for 
swallowing. This is accomplished by reducing the size of the ingested 
food and making it soft with the help of salivation and this entire process 
continues until all the food is ready for swallowing. A smooth but tight 
co-ordination between the cyclic movement of the jaw and the 
movements of the tongue, cheek, soft palate and hyoid bone is essential 
for swallowing. 
 
During drinking of liquid, the bolus is held in the oral cavity by the 
sealing of the posterior oral cavity by tongue-palate contact during the 
oral preparatory stage. Whereas during the food processing stage, there is 
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open communication between the oral cavity and the pharynx which is 
facilitated by the cyclical movement of the tongue and soft palate along 
with the jaw movement (6,9). Thus, the posterior oral cavity is not sealed 
during eating. The foods aroma is delivered to the chemoreceptors in the 
nose by the movements of the jaw and tongue which pumps air into the 
nasal cavity through the pharynx (10-12).  
 
The jaw movement is coordinated with the cyclical movement of 
tongue during processing. These movements are particularly large in the 
antero-posterior and vertical dimensions for the tongue (13) and the same 
in the vertical dimension for the jaw. The tongue moves forward and 
downward during jaw opening and reaches its anterior most point during 
mid or late jaw opening. This cyclical tongue movement with the jaw can 
cause us to bite our tongue and for the same reason the tongue moves 
backwards as well during late jaw opening. During chewing, the tongue 
moves medio-laterally and also rotates on its antero-posterior axis (14). 
The food is kept on the occlusal surfaces of teeth by the coordination of 
the tongue movements with the cheek movements. The hyoid bone is 
connected with the cranial base, mandible, sternum and thyroid cartilage 
through the suprahyoid and infrahyoid mucles and due to which it plays 
an important role in the movement of the tongue and jaw. 
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Movements of the jaw, hyoid and tongue A) or soft palate B)over time. Vertical 
positions of A) the anterior tongue marker (ATM), lower jaw and hyoid bone and B) 
soft palate, lower jaw and hyoid bone, each in a complete feeding sequence. 
Movement towards the top of the figure is upwards. Positions of the structures are 
plotted relative to the upper jaw over time. Rhythmic movement of the tongue and 
soft palate is temporarily linked to cyclic jaw movement. The hyoid also moves 
rhythmically; the amplitude of hyoid motion is greater in swallowing than in 
processing cycles. 
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2) Stage II Transport: When the ingested food becomes suitable for 
swallowing it is propelled through the fauces into the oropharynx 
after being placed on the surface of the tongue. This phase of 
swallowing is similar to that of the oral propulsive phase of 
swallowing for a liquid bolus. As it is in the propulsive phase for a 
liquid bolus, the tongue first comes in contact with the hard palate 
just behind the upper incisors and subsequently from forward to 
backward the area of tongue-palate contact increases which in turn 
squeezes the bolus back against the palate and finally into the 
oropharynx. This phase of swallowing is primarily driven by the 
tongue and does not require gravity (15,16). Food processing 
cycles can be interposed with the phase of bolus transport. Once 
the food is transported into the oropharynx, it accumulates in the 
pharyngeal surface of tongue and valleculae. If there is food 
remaining in the oral cavity, chewing continues and the bolus in 
oropharynx increases in size by the subsequent transport cycles. In 
normal individuals the duration of transport phase which includes 
bolus aggregation after food processing range from a fraction of a 
second to about ten seconds (6). 
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Figure depicting phase-II Transport 
 
 
PHARYNGEAL PHASE: 
The pharyngeal phase is the shortest but the most complex phase as it 
does not involve any pharyngeal activity until the swallowing reflex is 
triggered. It is completely involuntary when compared to other phases of 
swallowing. The swallowing reflex lasts for only 1 second and involves 
the motor and sensory tracts from glossopharyngeal and vagus cranial 
nerves. Pharyngeal phase of swallowing is an important,rapid, 
involuntary phase of swallowing which lasts only for about a second and 
includes two crucial features:  
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• Food passage – involves the basic passage of food from the 
pharynx through the UES into the esophagus. 
• Airway protection – To prevent the food from entering the airway 
by moving the larynx and trachea away from the pharynx. 
 
When a food particle accidently enters the larynx, reflex, which 
immediately tries to expel the same, is known as “cough reflex”.   
In this phase of swallowing, the bolus is made to enter into the pharynx 
without allowing regurgitation of food bolus in to the Nasopharynx and 
this is accomplished when the soft palate elevates and closes the 
Nasopharynx.  
 
The base of tongue retracts 
 
 
Bolus pushed against PPW 
 
 
Constrictor muscles contract, squeezing the bolus downward 
 
 
Pharynx also reduces in volume by shortening vertically 
	   19	  
The critical aspect of this phase of swallowing is to prevent the 
food bolus from entering the larynx and this is possible with the help of 
various protective mechanisms. The mechanisms involved in preventing 
aspiration include  
• Prior to opening of UES, the arytenoids bend forward to contact 
epiglottis and vocal cords close the larynx (17,18). 
• The thyrohyoid and supra-hyoid muscles contract to pull the 
hyoid bone and larynx upward and forward allowing the larynx 
to be tucked behind base of tongue.  
• Finally, the backward tilt of the epiglottis closes the laryngeal 
vestibule. 
It is unclear how this tilting of epiglottis occurs, but may probably be due 
to (19): 
• Elevation of Hypopharynx and larynx  
• Constriction of pharynx 
• Movement of bolus 
• Retraction of tongue base 
 
The entry of bolus into the esophagus is felicitated by the opening 
of the UES, which consists of constrictor muscles mainly inferior group, 
cricopharyngeus muscle and proximal part of esophagus. Tonic muscle 
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contraction (20,21) allows the closure of the UES. Three important 
factors contribute to the UES opening. 
• Cricopharyngeus muscle relaxation: this relaxation either occurs 
prior to the UES opening or the arrival of the bolus. 
• The opening of the UES is also achieved by pulling the hyo-
laryngeal framework forward. This is felicitated by the 
contraction of the supra-hyoid muscles and thyrohyoid muscles.  
• The UES distends due to pressure of the approaching bolus 
which in turn assists in its opening (22).  
 
The active process of UES opening by the contraction of the supra hyoid 
and thyro-hyoid muscles is the most important mechanism of all. This 
sphincter opening differs from other such openings in the body, as it is an 
active process unlike others, which are passive. 
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The pharyngeal phase of swallowing occurs as follows: 
 
Pharyngeal peristalsis- Contraction of the superior constrictor and BOT 
propelling the bolus backward 
 
 
Cessation of respiration (expiration) 
 
 
The bolus is driven around the opening of the pharynx by the elevation of 
the larynx and retro-flexion of the epiglottis 
 
The base of epiglottis and arytenoids are approximated 
 
 
Dilatation of UES further propels the bolus into the esophagus 
 
 
The bolus is then allowed to enter the upper esophagus by the relaxation 
of the constrictors and the UES. 
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Diagram of liquid bolus swallowing 
 
ESOPHAGEAL PHASE: 
Anatomically, esophagus is a tubular structure that extends from 
the UES to the LES. The LES is kept closed at rest by the tonic smooth 
muscle contraction to prevent the regurgitation from stomach. The 
esophagus can broadly be divided into upper one third and lower two 
thirds. The upper one third is innervated by skeletal muscles and lower 
two thirds by smooth muscle. The transport of bolus is different in the 
thoracic esophagus when compared to the pharynx because it is 
controlled by the autonomic nervous system and is true peristalsis. The 
food bolus from the pharynx reaches the upper esophagus through the 
UES and at this point a peristaltic wave begins in the esophagus, which 
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carries the bolus to the stomach through the LES. The esophageal 
peristalsis wave consists of two main components: 
• First the bolus is accommodated in the esophagus by a wave of 
relaxation. 
• The bolus is then propelled down by a wave of contraction.  
• In an upright position, gravity helps. 
 
Bolus location at swallow initiation in normal swallows: 
Swallowing is elicited as a measure of position of the head of the 
bolus relative to the time of pharyngeal swallow. The commonly used 
marker for this measurement is the point where the x ray shadow of the 
ramus of mandible crosses the pharyngeal surface of the tongue. Earlier it 
was assumed that the pharyngeal swallow is triggered when the head of 
food bolus passes the fauces as per VF. Delayed swallow initiation is 
when the bolus crosses the lower border of the mandible more than 1 
second before swallow initiation. It is considered as an important finding 
as the larynx is open at this point when the bolus is approaching. 
 
However, it was recently found that in healthy individuals drinking 
liquids the pre-swallow bolus enters into the pharynx also (23-25). The 
chewing bolus is furthermore accumulated in the oropharynx or 
valleculae prior to swallowing. It is now known that the position of the 
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bolus at swallow initiation is quite variable and is especially true when 
the bolus has both solid and liquid components. Saitoh et al. said that the 
leading edge of the food often entered the hypo-pharynx before 
swallowing in healthy young adults when the food bolus has both solid 
and liquid components. And because of this the liquid reaches the larynx 
when it is open. 
 
At swallow initiation and in case of swallowing of liquid it alters 
the location of the bolus. When the larynx remains closed between 
swallows, before pharyngeal swallow initiation the bolus head often 
reaches the valleculae (23,26-29). 
 
 
Peristaltic contractions propel the bolus for about 27cm from the 
cricopharyngeus through the thoracic esophagus 
 
 
The bolus reaches the gastric cardia when the LES relaxes 
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Coordination among eating, swallowing and breathing: 
Breathing along with eating and swallowing are tightly and 
precisely coordinated. In normal individuals, swallowing is dominant 
over breathing (30-32). During swallowing breathing ceases briefly not 
only because of the physical attribute of the tilting of epiglottis and 
arching of soft palate but also because of the neural suppression of 
breathing at the brain stem (31). Swallowing usually starts with the 
expiratory phase of breathing when drinking a liquid. When swallowing, 
respiration ceases for about 0.5s to 1.5s and continues to be in the state 
and breathing resumes in the expiration phase (33-35). This is considered 
to be a protective mechanism to prevent the left over food in the larynx 
entering into the larynx (36). Where as during sequential swallowing, 
while drinking from a cup respiration restarts with inspiration (37). 
 
As with liquids, when eating solid food also the respiratory rhythm 
is altered. The rhythm is altered right from the onset of mastication. 
During mastication, the respiratory cycles duration decreases but with 
swallowing, the “exhale – swallow – exhale” temporal relationship holds 
good (32,38,39). However, the breaks are longer, sometimes beginning 
much before swallow onset (12,39,40).  
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VFG and FEES images of bolus entry in the pharynx with two-phase 
 
 
1.3 DYSPHAGIA: 
Dysphagia is derived from the Greek words ‘dys’, meaning 
difficulty and ‘phagia’ meaning to eat (1). Dysphagia occurs due to a 
mechanical obstruction or neurological disassociation leading to 
disruption of peristalsis, which impairs the transport of a liquid or a solid 
food bolus along the pharyngo-esophageal conduit. The common 
complaint of patients with impaired swallowing is that they find it 
difficult to initiate swallowing or feeling of food sticking or stopping on 
its way to the stomach. The cause of dysphagia could either be functional 
or organic (41,42). Dysphagia could be either episodic or start with 
difficulty for solids and gradually worsen. Episodic dysphagia, which 
occurs for both liquids and solids usually, suggests a motor disorder. 
When the dysphagia is initially for solids and gradually worsens to liquid 
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diet, it usually suggests a functional deficit or a structure and in case of a 
similar progression, which is more rapid and associated with weight loss, 
it is thought to be malignant. From a clinical point of view it is essential 
to identify whether it is oropharyngeal or esophageal dysphagia. 
Dysphagia may also lead to severe complications like: 
• Dehydration 
• Malnutrition 
• Pneumonia 
• Airway obstruction 
 
Dysphagia could be due to either structural or functional abnormalities. 
 
Structural Abnormalities: 
The structural abnormalities causing dysphagia can be either 
congenital or acquired. One commonly seen congenital abnormality is the 
cleft lip and palate. Due to this abnormality the labial control for sucking 
is impaired, the oral suction is decreased, difficult to maintain the oral 
pressure and causes nasal regurgitation, as there is insufficient velo-
pharyngeal closure. The mastication also is impaired due to the under 
growth of the palate and mal alignment of the teeth. 
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Some of the other congenital structural abnormalities are: 
• Cervical osteophytes – commonly seen in the elderly. As the 
name suggests, they are outgrowths from the cervical vertebrae. 
They tend to direct the food into the airway as the food pathway 
is narrowed (~ 50%) (43). 
• Diverticula – is a pouch, which may be present in the pharynx 
or the esophagus. It usually occurs in a weak spot in the 
muscular walls. A Zenker diverticulum occurs in the 
Hypopharynx with its opening at the cricopharyngeus but the 
body may be much lower (44). From the diverticulum the bolus 
can be regurgitated into the pharynx causing cough or 
aspiration. 
• Webs or strictures – They obstruct the food passage and usually 
more symptomatic with solid food than liquids. They may occur 
anywhere from the sphincters to pharynx or esophagus. The 
common site for such strictures is narrowing at the UES.  
 
Failure to open the UES may be due to weakness of muscles or due 
to webs or strictures i.e. it might be structural or functional (45). In such 
cases dilatation is the intervention of choice but at the same time it gets 
difficult to differentiate such conditions. The most common site for a 
stricture to occur is the body of the food pipe i.e. esophagus. It is often 
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diagnosed in patients with GERD (gastro-esophageal reflux disease) but 
esophageal carcinoma should always be considered in the differential 
diagnosis as it is a serious condition and appropriate and timely 
intervention can improve both the survival and quality of life. 
 
Functional Abnormalities: 
Oral Cavity:  
Functional Abnormalities affecting any of the parts of oral cavity i.e., the 
cheek, jaw, lips or tongue can impair the food-processing phase. 
 
• Drooling caused by reduced closing pressure of lips.  
• Leakage of the bolus into the pharynx, mainly liquids due to 
weak and premature contraction of the tongue and soft palate. 
• Trapped food in between lower teeth and cheek or gums i.e. 
buccal or labial sulci due to weakness of buccal or labial 
muscles. 
• Incoordination and weakness of tongue can cause impaired 
mastication and bolus formation and transport. In some cases 
senosory deficit also produces similar impairments and also 
excessive retention of food in oral cavity after swallowing.   
• In the same way Xerostomia also impairs food processing, 
bolus formation and transport (46). 
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• Masticatory performance is reduced by any loss of teeth. Due to 
this reduced performance chewing could be delayed and particle 
size of swallowing bolus might be larger. 
• In patients with carcinomas of the head and neck being treated 
with chemo radiation therapy are often found to be symptomatic 
due to delay in swallowing initiation, reduced pharyngeal 
transport, and insufficient laryngeal protection (47). 
 
Pharynx: 
In pharynx, any impairment of its function can cause defects in initiation 
of swallowing, propulsion of the bolus, and formation of bolus and 
retention of food in the pharynx after completion of swallowing. 
• Reduction in pressure during pharyngeal swallow affecting the 
transport through UES and regurgitation of food to the 
Nasopharynx may occur due to insufficient velo-laryngeal 
closure. 
• Insufficient force of pharyngeal propulsion causing retention of 
all or a part of the food bolus in the pharynx, usually in the 
valleculae and pyriform sinuses may be due to impaired tongue 
base retraction or weakness of pharyngeal constrictors. 
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• In case of high viscosity boluses, there may be obstruction of 
bolus propulsion and retention of food in the valleculae due to 
incomplete tilting of the epiglottis. 
• Increased risk of aspiration of the food retained in the piriform 
sinuses and Hypopharynx after swallow may occur due to 
impaired opening of the UES causing obstruction of the food 
way either partially or totally. Impaired opening of the UES can 
be caused either by fibrosis or inflammation resulting in 
increased stiffness of the sphincter or failure to relax the 
sphincter musculature. Also, weakness of another set of 
muscles, which normally pull the sphincter open during 
swallowing, can cause impaired UES opening and these 
muscles are the anterior suprahyoid muscles. 
 
Esophagus: 
Next is, esophageal dysfunction. This is common compared to oral cavity 
or pharynx and characteristically does not often show any symptoms. 
Motor disorders of the esophagus include conditions, which are of: 
• Hyper-activity (e.g. spasm)  
• Hypo-activity (e.g. weakness) or  
• Incoordination of the musculature (48) 
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Any of the above conditions can lead to retention of food in the 
esophagus due to inadequate or ineffective peristalsis. This food retention 
in esophagus after swallowing may cause regurgitation of the food into 
the pharynx, which may lead to aspiration of the regurgitated material. 
Sometimes these motor disorders are caused by gastro esophageal reflux 
disease, and can sometimes respond to treatment with proton pump 
inhibitors (PPIs). 
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Cervical Osteophytes – 50% luminal narrowing noted in a barium swallow in a 
patient with C6-C7 (arrow) osteophyte. 
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Protection of airway – penetration/aspiration   
Airway protection is an integral and the most essential feature of 
the whole process of swallowing. Failure at any level to protect the 
airway may lead to serious consequences.  
 
Laryngeal penetration is observed when the processed food bolus from 
the oral cavity or the regurgitated material from the esophagus or retained 
food particles in the pharynx enters the larynx just above the level of true 
vocal cords.  
 
Aspiration is defined when the same food bolus entering the larynx 
passes through the vocal folds.  
 
We can observe laryngeal penetration in some normal individuals 
as well but in case of aspiration, which is noted in endoscopy or 
fluoroscopy is considered to be pathological, and in such a case there is 
always a high risk of obstruction of airway and aspiration pneumonia 
(49). Such an aspiration can occur anytime either before, during or after 
swallowing. For clinical purposes the mechanism of aspiration should be 
noted if observed in fluoroscopy or endoscopy. Mechanism of airway 
protection during the swallow can be impaired by: 
• Reduced elevation of hypo-laryngeal framework  
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• Impairment of epiglottic tilt  
• Incomplete closure of the laryngeal vestibule 
• Inadequate vocal cord closure due to weakness or paralysis, 
or fixation.  
Aspiration before the swallow is commonly caused by: 
• Liquids entering into the pharynx directly (due to impaired 
hold in the oral cavity)   
• Laryngeal closure occuring after a bolus is already entered 
into the larynx 
 
And lastly, aspiration occurring after the swallow is usually due to 
residual food bolus in the pharynx after the swallow. The material could 
be inhaled when breathing is resumed after completion of the swallow.  
 
The subsequent consequences due to aspiration can be very 
variable, ranging from no apparent effect all the way to complete airway 
obstruction or even severe pneumonia. In normal healthy individuals, the 
response to aspiration is strong cough or throat clearing but in individuals 
suffering from severe dysphagia the laryngeal sensation is often abnormal 
(50). Aspiration in which there is no apparent clinical response or Silent 
aspiration has been reported in 25-30% of individuals who have been 
referred for dysphagia evaluations (50,51,52). 
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Penetration and Aspiration  
VF images of laryngeal penetration and aspiration in dysphagic patients swallowing 
liquid barium. Arrow indicates the leading edge of barium. 
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The effect of aspiration in an individual can be determined by many 
factors including: 
• Quantity of the aspirate  
• Depth of the aspiration material in the airway  
• Physical properties of the aspirate (if the material is acidic it is 
most damaging to the lung, causing chemical pneumonitis)  
• Individual’s pulmonary clearance mechanism.  
Risk of bacterial pneumonia is increased by an aspirate in an 
individual who maintains poor oral hygiene (53).    
 
Oropharyngeal Dysphagia: 
Complaint - Difficulty getting the food bolus to the back of the throat or 
that food gets stuck in the back of the throat.  
Signs –Include cough reflex, regurgitation through the nose and the 
individual choking immediately after swallowing. They also face a 
greater difficulty swallowing the liquids than solids. 
Esophageal Dysphagia: 
Complaint – Food sticking in the sub sternal region or the sternal notch. 
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Signs – To determine the timing of the symptom by observing the patient 
swallow. Incase of esophageal dysphagia, the onset of dysphagia 
sensation occurs several seconds after swallowing begins. 
 
Evaluation of Dysphagia: 
Physical examination:  
• To rule out pre-existing disorders general history regarding body 
habits, history of drooling and current mental status should be 
noted. 
• The PPW motion on phonation and movement of the palate 
(elevation) should be inspected in the oropharynx. 
• The presence of pooled secretions in the larynx makes it difficult to 
examine the larynx, which is very essential for evaluation of 
dysphagia. 
 
Investigations: 
• Plain films – Inflammatory (epiglottis, retro-pharyngeal abcess) 
• Barium esophagram – Can be used in individuals in whom 
structural defects are suspected. 
• Manometer – Barometric measurement of the intra-luminal 
pressures. Rarely used.  
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• Bolus Scintigraphy – Used to follow the progress of a patient, with 
history of aspiration or to follow esophageal emptying. 
• Video-fluoroscopy or modified barium swallow – “GOLD 
STANDARD”, to assess the proper functioning of the oral and the 
pharyngeal phases of the process of swallowing. 
• Endoscopy – Direct pharyngoscopy or upper GI endoscopy or 
esophagography is the initial diagnostic study of choice in a patient 
who has a history of esophageal dysphagia, and the history suggesting 
the presence of a pharyngeal or esophageal lesion.  
 
1.4 Dysphagia in Head and Neck Cancers:  
Dysphagia as a presenting symptom and also treatment related 
dysphagia is an important factor influencing the treatment tolerance and 
QOL of patients with head and neck cancers. Previously, surgery 
followed by adjuvant therapy was the standard of care for such patients. 
With the advent of the concept of organ and function preservation aiming 
at a better quality of life for such patients, there also has been 
intensification of therapy regimens in order to improve tumour control 
rates. The same has been achieved but with the consequence of added 
morbidity and an effect on post treatment QOL. The aim of radiation for 
malignancy of any site is to achieve maximum dose conformity to the 
tumour site and least possible dose exposure to the surrounding normal 
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tissue. This depicts the intensity and rate of incidence of associated side 
effects of treatment. The main sequela related to these intensified 
regimens for patients with head and neck malignancy is dysphagia (54).  
 
Several studies have proven improved overall survival and better 
tumour control rates when RT alone in head and neck cancers was 
compared to RT concurrent with cisplatin and one such landmark study 
was the Radiation Therapy Oncology Group (RTOG) 91-11. In this study 
however, when toxicity profile in terms of dysphagia was observed, it 
was found that at the end of one year post therapy 23% of the patients 
were not able to eat solid or liquid food in the chemo-RT arm when 
compared to only 9% patients showing dysphagia in the RT alone arm 
(55).  
 
There are other studies, which concentrate on intensifying these 
chemo-RT regimens in an attempt to achieve better tumour control rates, 
but such studies have reported a feeding-tube dependence rate of about 
20% at the end of one year in the experimental regimens (54). Recent 
evidence has shown that aspiration along with dysphagia in an important 
sequel of chemo-RT regimens but in many cases is not reported or not 
given the same importance (56,57).   
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In any case, patients being treated with RT for any malignancy, the 
main objective of treatment is to achieve maximum dose conformity and 
the least dose possible to the surrounding normal structures. With such an 
aim, it is possible to reduce the subsequent morbidity in patients even 
with the use of intensive chemo-RT regimens. When we consider 
dysphagia and aspiration to be important sequel of treatment in head and 
neck cancers, achieving required dose constraints to the anatomic 
structures, which are responsible for the same, QOL of such patients can 
be significantly improved along with achieving the desired local tumour 
control. 
 
In terms of toxicity, early onset symptoms can be controlled or 
managed with temporary gastric tube feeding. Chemo-RT regimens or 
aggressive accelerated RT gained ground and became the preferred 
treatment of choice with the introduction of concept of “functional 
preservation” or “organ preservation”. Such an approach has no meaning 
when the preferred intensive treatment regimens aimed at high tumour 
control but produce long term persistent toxicity thus depriving a good 
QOL. Apart from late and persistent dysphagia, intensive treatment 
regimens with concurrent chemo-RT or accelerated RT are also found 
associated with late laryngeal edema, chance of aspiration and an 
increased risk of pneumonia. Recently it has been concluded that late 
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pharyngeal toxicity is the only hindrance to achieving the best possible 
control rates. Efforts should be directed towards improving the 
therapeutic ratios with the help optimal chemo-RT regimen aimed at 
maximum possible dose conformity. 
 
If such target dose conformity can be achieved and the dose 
delivered to the anatomic structures responsible for dysphagia and 
aspiration can be reduced then the incidence and severity of dysphagia in 
such patients can be considerably reduced. To address and investigate this 
issue, many recent studies have been initiated. For such an investigation, 
first step is to identify the anatomic structures whose damage or 
abnormality cause dysphagia or aspiration. In one such study by Avraham 
eisbruch et.al (58) identified the pharyngeal constrictors (PC) and the 
glottic and supraglottic larynx (GSL) as the structures whose anatomic 
structural changes and malfunction cause post therapy 
dysphagia/aspiration. Once these structures were identified, efforts were 
made towards implementing modified strategies aiming at reducing the 
dose to these structures. Few such strategies were based on intensity-
modulated radiotherapy (IMRT), namely dysphagia/aspiration-specific 
IMRT which improved the sparing of these structures thus resulted in 
reducing the dose delivered to these structures when compared to 
standard IMRT plan which does not involve giving such dose constraints 
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(58). However, in any case utmost care should be taken that in an attempt 
to spare the dysphagia related structures the target tumour volume should 
not be missed or under-dosed. 
 
1.5 Review of Literature: 
1. Avraham eisbruch et.al. has done a study aimed at identifying the 
structures whose anatomic or functional abnormality cause 
impaired swallowing leading to dysphagia and aspiration. They 
also studied the feasibility of sparing of such structures using 
specialized IMRT strategies in which care was taken not to 
compromise the target tumour volume. A total of 26 patients were 
taken up for this study. They received concurrent chemo-RT with 
gemcitabine regimen, an intensive regimen, which is known to be 
associated with increased incidence of dysphagia related toxcicity.  
To make sure that the morbidity is not regimen specific, 6 patients 
also received RT with intra-arterial cisplatin. Apart from this, the 
possibility of sparing of dysphagia and aspiration related structures 
was explored with the help of modified IMRT strategies (doIMRT) 
and not compromise on the target volume. The VF abnormalities 
were noted in both pre and post treatment scenarios along with 
subjective assessment of dysphagia. This study identified the post-
therapy VF abnormalities, which were found to be common to both 
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the chemotherapy regimens. The abnormalities noted which 
contributed to a high rate of aspiration were:  
• Larynx being elevated 
• Impaired laryngeal closure 
• Tilting of the epiglottis 
This study also helped to identify the anatomical structures by 
observing the changes in those who’s structural or functional abnormality 
can result in dysphagia and aspiration. These structures were identified as 
the pharyngeal constrictors (PC) and larynx and supraglottic larynx 
(GSL). The planning goal was set so that these structures receive a mean 
dose of about 50Gy by reducing the volume of these structures receiving 
more than 55Gy. It was concluded that the structures whose anatomical 
deformity are responsible for causing dysphagia and aspiration to be 
pharyngeal constrictor muscles (PC), glottic and supra glottic larynx 
(GSL). When compared to 3DCRT, the use of specialized and optimized 
IMRT plans were able to spare these structures. The dosimetric goal was 
achieved with the help of IMRT better than 3DCRT but a clinical 
validation is required to check whether the dosimetric gains translate into 
clinical ones.  
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2. Felix.y.Feng.et.al - have presented initial results of a clinical trial 
in which intensity-modulated radiotherapy (IMRT) was used to 
reduce the dose delivered to the swallowing structures whose 
impairment after chemo-radiation is most likely to cause 
dysphagiaand aspiration, but never compromising the target 
volume dose. This is a prospective longitudinal study, which 
included patients of stage I- IV of Nasopharynx and oropharynx. 
All these patients were treated with definitive chemo IMRT 
regimen with an aim to spare the dysphagia related structures 
which include the pharyngeal constrictors (PC), glottic and supra 
glottic larynx (GSL). Since the retropharyngeal nodes are in close 
approximation to the constrictors, lateral nodes were considered to 
be high risk but not the medial RP nodes. Evaluation of dysphagia 
was done using video-fluoroscopic images and patient reported and 
observed reported scores were considered. The relation between 
the dose received by these structures and the structural changes 
observed in these structures were compared from before therapy to 
3 months after therapy.  
 
There was a significant change noted in videofluoroscopy-based 
aspirations when these changes observed were compared to the mean 
doses received by these structures. The mean doses as well as the partial 
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volumes of these structures (PC and GSL) receiving 50-65Gy were 
significantly correlated when compared to the videofluoroscopy-based 
aspirations; the most significant correlations were found to be with the 
superior pharyngeal constrictor (p = 0.005). It was also found that in all 
the patients who had aspirations, the mean dose to the pharyngeal 
constrictors was  >60 Gy or volume of PC receiving 65 Gy was more 
than 50%, and the volume of GSL receiving more than 50Gy was more 
than 50% as well.  
 
The mean PC and GSL doses correlated well with reduced 
laryngeal elevation and epiglottic inversion (p < 0.01). All the patients 
with strictures (3) had PC V70 >50%. Patient related dysphagia co-
related with mean doses to the PC. Such dose-volume relationships 
provide optimized IMRT goals and increase our interest to put in 
increased efforts to reduce doses to swallowing and thereby reducing the 
incidence of dysphagia and aspiration.  
 
 
3) Jaiprakash Agarwal et al. - This study was done to objectively assess 
swallowing and the factors affecting it in patients with squamous cell 
carcinoma of head and neck (HNSCC) who have been treated with 
definitive chemo-RT regimen and a curative intent. A cohort of 47 
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patients with loco-regionally advanced (T1–4, N0–3) HNSCC who were 
treated with definitive CRT was taken for this study. The swallowing was 
assessed objectively with the help of scoring of MBS in pre-CRT as well 
as the subsequent follow-ups. The score was done using the penetration–
aspiration scale (PAS). Any abnormality in swallowing was weighed in 
terms of severity and incidence of penetration-aspiration, residue in 
pharynx, change in posture and regurgitation.  
 
In the pre-CT assessment 9 patients showed aspiration where as at 
6 months post CRT this was found to increase to 11 patients (19% to 
29%). In the same way when pre-CT assessment was compared to 6 
months post CT residual material in pharynx changed from 11 patients to 
13 patients (23% to 29%) postural change was found to be increasing 
from 10(21%) to 12(32%) patients and finally regurgitation was found to 
be in patients 5 patients and 10 patients (10% to 26%). When PAS scores 
were observed the proportion of patients with high PAS scores (3-7) also 
increased from 27%V to 37% from baseline to 6 months post CRT. The 
patients who had low PAS scores at baseline, were found to have 
additional impairment of swallowing function at 2 months and 6 months 
post CRT follow up study. In post CRT study a high proportion of 
patients were found to have impairment in the residue and aspiration 
groups. The consistency of barium, thin and thick barium were found to 
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influence the rate of aspiration or residue. Thick barium had higher 
function of residue and thin barium showed a higher function with 
aspiration. Patients who had pre CRT poor swallowing function, with 
hypo pharyngeal primary and large volume disease were found to have 
worse objective swallowing proven with the help low PAS scores ta 
baseline.  It was concluded that there is statistically significant 
impairment in objective swallowing in all aspects of swallowing i.e, 
aspiration, residue, regurgitation and postural change and found to be the 
most in aspiration and residue domain. The patterns of objective 
swallowing dysfunction in patients with HNSCC being treated with CRT 
were made clear in this study. 
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AIM 
This is a study aimed at assessing the clinical advantages 
achieved with the help of different IMRT strategies (standard 
IMRT and dysphagia/aspiration-specific IMRT). This is a 
prospective study which mainly focuses on the clinical advantages 
of reducing the dose received by the swallowing structures, 
pharyngeal constrictors (PC), glottic and supraglottic larynx (GSL) 
and esophagus, and the corresponding changes in the subjective 
and objective swallowing dysfunction and aspiration from before 
the start of treatment to 3 months after end of treatment. It focuses 
on reducing the volume of these structures receiving doses more 
than 50Gy but also emphasize on the importance of compromising 
the target volume. The primary end point of this study is to analyze 
dysphagia in patients treated with sparing of swallowing structures 
and secondary end point is to compare this to retrospectively 
analyzed patients without constraints for dysphagia structures. 
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MATERIAL AND METHODS 
 
This is a prospective, longitudinal study among patients 
being treated with chemo-IMRT for squamous cell carcinoma of 
head and neck who were being treated with radical chemo-RT with 
a curative intent. The main objective of this study is to assess the 
dysphagia resulting from treatment. 
 
In order to avoid tumor-related effects on the endpoints of 
this study, it was decided to exclude patients with laryngeal or 
hypo-pharyngeal cancer because such cases have high incidence of 
pre-treatment pre-existing swallowing dysfunction and aspiration  
(disease-related) (59). Thus, the disease related factor was 
excluded to study the effects on treatment related dysphagia only. 
 
Inclusion Criteria 
• Cancer of Nasopharynx and Oropharynx  
• Stage 3 and 4(T2-T4, N+) 
• Histology of squamous cell carcinoma, poorly diff carcinoma and 
NPC 
• All ages 16 – 70yrs 
• ECOG PS < 2 
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Exclusion Criteria 
• Hypopharynx and laryngeal cancers 
• History of previous neck irradiation 
• Patients receiving only radiation 
 
 Radiotherapy 
The principles of target selection and IMRT planning followed are 
as per the general consensus of target delineation in head and neck 
cancers (60,61). In case of Nasopharynx or oropharynx the whole neck 
needs to be covered in the target volume. When using two opposing 
lateral fields to treat the primary and neck, the coverage of lower neck 
becomes an issue. There are two ways in which that can be achieved. 
One, by including the whole neck in the IMRT plan and delineating the 
nodal GTV and CTV and the other way is to add an anterior lower neck 
field. With a lower neck anterior field, the deeper targets will be under 
dosed and for the same reason we have avoided using an anterior field.    
 
Delineation of retropharyngeal (RP) nodes was given due 
importance in this study. These nodes are defined as targets for all 
nasopharyngeal and almost all oropharyngeal cases and especially in 
cases with other clinically involved nodes.  
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The retropharyngeal nodes are bounded anteriorly by the 
pharyngeal constrictors and pre-vertebral fascia covers posteriorly, 
superiorly the extent is up to the base of skull and up to the level of C3 
cervical vertebra inferiorly (62). The retroperitoneal nodes are divided 
into two groups, lateral retropharyngeal and the medial retropharyngeal 
nodes. The lateral nodes are located medial to the carotid arteries but 
lateral to the longus coli and capitis muscles. The medial nodes are 
present along with the lymphatics near the midline. For the purpose of 
allowing sparing of the pharyngeal constrictors, the lateral nodes alone 
where considered high risk for nodal metastases, as they are known to be 
in all head and neck cancers and especially in nasopharyngeal cancers 
(63-73). The medial RP nodes were not included as targets unless there 
was a gross radiological involvement of the lateral RP nodes, as they 
were found to be rarely involved. The medial RP nodes were not included 
in the nodal target volume as they were found to be rarely involved. 
These nodes were considered to be at high risk or included in the target 
volume only if there were found to be grossly involved radiologically.   
 
While defining target volumes, the planning target volumes (PTVs) 
were created using a uniform margin of about 0.5cm from the clinical 
target volume (CTV) which accounts for the daily setup errors which 
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were monitored based on weekly imaging (daily imaging not feasible in 
current set-up) and not allowed to be anything beyond 1-1.5mm.  
 
Contouring of the swallowing structures includes pharyngeal 
constrictors (PC), glottic – supraglottic larynx (GSL) and esophagus. The 
contouring of these structures was done based on anatomic atlases. The 
PC was contoured as a single organ starting at the level of pterygoid 
plates superiorly and inferiorly up to the level of lower border of cricoid 
cartilage. The PCs are divided into superior, middle and inferior 
constrictors for the purpose of analysis. The superior constrictors begin 
from base of skull up to the upper edge of hyoid bone. The middle 
constrictors extends through the superior edge of hyoid bone to inferior 
edge and the inferior PC is from the hyoid up to the inferior edge of 
cricoid cartilage. In the same way, the glottic and supraglottic larynx was 
contoured as one single organ starting at the level of epiglottis (according 
to the latest TNM classification, epiglottis is included as a sub site of 
supra glottic larynx) up to the lower border of cricoid cartilage, which 
anatomically marks the beginning of the upper esophagus i.e. the 
cricopharyngeus muscle.  The esophagus was contoured from the inferior 
edge of cricoid up to the level of caudal extent of the lower neck fields.  
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Clinical target volumes (CTV) with PTVs in respect to RP nodes (red) and PCs – 
yellow  
CTVs of the lateral RP nodes – green 
Retropharyngeal space medial to carotids – asterisks 
CTVs do not include the medial RP nodes – marked by blue and long arrows. 
 
The dose prescription includes all the targets delineated in high risk 
PTV to receive TD-60-66Gy at 200cGy DD/fraction and TD 50-55Gy to 
sub clinical/low risk PTV. With the help of in house planning systems 
(VARIAN), inverse IMRT plans were analysed and executed once target 
dose homogeneity is achieved (74). An optimized IMRT plan was thus 
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generated (study IMRT) which included the dose given to the delineated 
PTVs as per the RTOG protocol along with an optimization goal to try 
and constraint the dose to the swallowing structures. The swallowing 
structures contoured were given a dosimetric goal of maximal dose of 
50Gy if and when they are contoured outside the PTV. No compromise to 
the primary target PTV was allowed while sparing these structures and 
for achieving optimum dosimetric goals, the structures that outside the 
PTV only were spared. 
 
In all patients, the prescription dose to the targets was considered 
as high priority and other critical organ dosimetric constraints were 
considered to be secondary except for maximal spinal cord dose. The 
optimized IMRT strategy for sparing of the swallowing structures was 
implemented by subtracting these structures from within the PTV and for 
the purpose of the study these dose prescriptions were considered to be 
clinically significant. For the whole structures and the parts that over 
lapped the PTVs, DVH analyses were performed and reported.  
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Dose specifications and constraints used for two IMRT strategies 
1. Standard IMRT 
Targets 
• PTV60 for the radiological gross disease; prescribed dose 60Gy in 
30 fractions 
 
Noninvolved tissues and organs 
• 2/3 of the glottic larynx should receive  >50Gy 
• Maximal dose to brain stem 54Gy 
• Maximal dose to spinal cord 45Gy 
• Maximal dose to mandible 70Gy 
All the non-specific tissues outside PTVs: <1% to receive <110% of 
PTV60 dose 
In at least one parotid gland, mean dose <26Gy or <50% receive <30Gy 
 
2. Study IMRT  
The dose specifications and constraints given are the same as that for 
Standard IMRT. 
In addition, the volume of dysphagia and aspiration related structures 
receiving >50Gy were reduced as much as possible without 
compromising target PTV. 
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(Abbreviations: IMRT - intensity-modulated radiotherapy; Standard 
IMRT - standard IMRT; PTV - planning target volume; PTV66=66Gy to 
PTV of gross disease; RTOG - Radiation Therapy Oncology Group) 
 
Chemotherapy 
• Oropharynx - Oropharynx- weekly cisplatin (40mg/m2) along with 
RT for minimum of 5 weeks. 
• Nasopharynx- 3 cycles of cisplatin (70mg/m2) once in 21 days 
along with RT followed by 3 cycles of cisplatin (70mg/m2) +5FU 
(IV bolus, 500mg from d1-d3) every 21 days, adjuvant therapy. 
 
Supportive care 
• Anti-emetics and adequate hydration both before and after 
chemotherapy was delivered following standard of care. 
• Among patients having dysphagia and malnourishment, 
nasogastric tube intubation was initiated. 
 
Evaluation of Dysphagia 
The evaluation of dysphagia and swallowing dysfunction in respect 
to aspiration and penetration was done from before therapy to 3 months 
after therapy both subjectively (patient-reported) as well as objectively 
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(observed). The primary end point of this study is to analyze the changes 
and the incidence of dysphagia in relation to the DVH of these structures. 
 
The objective or observed evaluation of swallowing was done 
using barium swallow studies using both thick and thin consistencies. An 
interventional radiologist was present to analyze the dysphagia and 
aspiration using PAS  (Table) (75). 
 
For evaluation, the movement of the barium was observed in real 
time and in slow motion. Frame-by-frame analysis was required in order 
to evaluate the function of oral, pharyngeal and laryngeal and UES. 
Swallowing dysfunction was defined in terms of either the incidence or 
severity of penetration–aspiration, residue in pharynx, swallowing 
regurgitation, and change in posture during swallow. When any portion 
of the bolus which is entering the laryngeal vestibule at the level of vocal 
cords but not passing below the vocal cords is known as Penetration. In a 
similar way aspiration is when the penetrated bolus passes below the 
level of the true vocal folds and finally enters the subglottic region. 
Portion of the swallowed bolus, which is left behind in the pharyngeal 
spaces such as valleculae and pyriform sinuses is nothing but the 
Pharyngeal residue. Barium swallow was repeated using thin and thick 
barium. 
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PAS on MBS - Interpretation: 1-2 = Normal; 3-6 = Penetration; 7-8 = Aspiration 
 
Patient-reported dysphagia was assessed with two validated head 
and-neck cancer–related quality-of-life questionnaires given to patients 
before therapy and 3 months after the completion of therapy. They 
included the Head and Neck Quality of Life (HNQOL) instrument (76) 
and the University of Washington Head and Neck-related Quality-of-Life 
(UWQOL) instrument (77).  
 
HNQOL – questionnaire contains two questions related to dysphagia 
• ‘‘How much are you bothered by swallowing liquids?’’  
•  ‘‘How much are you bothered by swallowing solids?’’ 
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Each having five possible answers –  
• ‘‘Not at all’’ 
• ‘‘Slightly’’ 
• ‘‘Moderately’’ 
• ‘‘A lot’’ 
• ‘‘Extremely’’ 
 
UWQOL - Contains one swallowing question with five possible answers  
•  ‘‘I swallow normally’’  
• ‘‘I cannot swallow certain solid food’’ 
• ‘‘I can only swallow soft food’’ 
• ‘‘I can only swallow liquid foods’’ 
• ‘‘I cannot swallow’’ 
 
 
Statistical Analysis 
The dose volume effect relationships of all the dysphagia outcome 
measures and dose values were modeled using multiple regression 
analyses, with the score of dysphagia using PAS scoring system, measure 
from before treatment to 3 months after therapy as the dependent 
variable. Statistical significance was determined at p < 0.05 (two-tailed).  
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Contouring of superior pharyngeal constrictors 
The contouring of the superior pharyngeal constrictors begins at 
the level of pterygoid plates. When the imaging modality used is CT 
scan, delineating the PC becomes difficult. The area near the midline, 
medial to the carotids, longus coli and capitis muscle is considered to be 
the PC. As mentioned earlier, the lateral RP nodes alone are considered to 
be high risk and accordingly, when contouring is done medial to the 
capitis muscle it will not include the lateral RP nodes in the PC contour. 
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Contouring of middle pharyngeal constrictors 
The contouring of the middle pharyngeal constrictor begins at the 
level of the superior edge of the hyoid bone and extends through it up to 
the lower edge of the hyoid. This part of the PC is the smallest of the 
three sub divisions.  Delineation the middle PC with respect to the RP 
nodes is the same when compared to the superior PC i.e. medial to the 
carotids. The involvement of the medial RP nodes is very rare especially 
in case of an oropharyngeal carcinoma.  
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Contouring of the inferior pharyngeal constrictor 
The inferior pharyngeal constrictor is contoured from the level of lower 
border of hyoid bone to the lower border of the cricoid cartilage. In such 
a case, the constrictor is found posterior to the larynx along the posterior 
pharyngeal wall. When contouring the GSL, there is a probability of 
overlap of contours between the three i.e. PC, GSL and the corresponding 
target volumes. 
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Topographic view of the contouring of the pharyngeal constrictors 
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Contouring of GSL beginning at the level of epiglottis 
The glottic and supra glottic larynx are also contoured as a single 
organ as in the case of pharyngeal constrictors. We have considered 
beginning the delineation of the supra-glottic larynx at the level of 
epiglottis since its incorporation into the supra glottic larynx as per the 
AJCC staging.  
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Topographic view of the contouring of GSL 
 
 
 
 
 
 
 
 
 
Contouring of the esophagus 
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Target Delineation 
Delineating the Gross tumour volume (GTV), Clinical target 
volume (CTV) and the Planning target volume (PTV) is an essential part 
of sparing of swallowing structures. Target delineation is essential since it 
defines the volume of each of the swallowing structures receiving the 
prescribed dose. Reducing the relative volume of these structures 
receiving total prescribed dose is the optimization goal. The image shows 
the entire target volume delineated with respect to sparing of PC and both 
the parotids. It can be noted that the volume of PC contoured comes 
within the GTV, CTV as well as PTV and so does the ipsilateral parotid. 
In such a case, any reduction in the PTV might result in missing or under 
dosing the PTV. Thus, the total volume of the PC and parotid in such 
cases will receive the entire prescribed dose of the PTV60 and a 
constraint becomes impossible. In case of oropharynx and Nasopharynx 
as in the case of this study, the superior constrictor and middle constrictor 
constraints become an issue as it is in the close proximity of the PTV. 
This is the reason why the optimization goal for this study is the 
maximum reduction in the volume of these structures receiving 50Gy 
rather than keeping the mean dose of total volume under 50Gy, which 
will result in compromising the target and should be avoided in all cases. 
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  Target delineation with PC and parotid contour at the level of hyoid 
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Case of oropharynx (bulky) – sparing of GSL not feasible  
 
 
Case of bulky Nasopharynx – superior PC sparing not possible 
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Sparing of the middle PC in a case of early stage of oropharynx 
 
 
Early stage disease where sparing the PC and GSL is feasible 
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Unilateral PTV Vs Bilateral PTV: 
Target delineation in the neck depends on the extent and stage of 
the primary. In early stage, well-lateralized disease, the recommendation 
is to treat only the ipsilateral neck. In such a case, the morbidity with 
respect to dysphagia, skin reactions can be kept at minimum. The volume 
of PC and GSL receiving PTV60 also is minimal. Whereas in cases 
where bilateral neck has to be treated i.e. bulky disease or locally 
advanced disease or bilateral neck node involvement, the sparing of PC 
and GSL becomes a little challenging. In order to facilitate this, an 
alternative is to split the PTV/CTV into two, one for each side of the neck 
and thus considerably reducing the volume of the GSL and PC receiving 
more than 50Gy. This may not be feasible in all cases i.e. with bulky 
nodal disease or multiple bilateral nodes where extra precaution is needed 
so that any of the target volumes are not compromised. There different 
ways in which the neck field can be planned. It can be delineated as a part 
of whole neck PTV in which case sparing of normal tissue becomes an 
issue except when IMRT is used. The alternative is to split the PTV for 
the neck as mentioned earlier and finally to use an anterior lower neck 
field. Anterior lower neck field is the least feasible option with respect to 
getting adequate dosage to the deeper lying targets. 
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Unilateral PTV with respect to GSL and PC 
 
Topographic view of Unilateral PTV 
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Target delineation in neck – two separate PTVs for bilateral neck 
 
 
Topographic view of two separate PTVs for either side neck 
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Target delineation in neck – single PTV for whole neck 
 
 
Topographic view of single neck PTV 
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RESULTS 
Patient characteristics: 
A total of 30 patients were considered for this study. 26 of these 
patients were treated with concurrent chemo-radiation and included in the 
study. All are patients of either oropharyngeal or nasopharyngeal 
carcinoma. Out of which 16 patients were oropharyngeal and 10 patients 
were Nasopharyngeal carcinomas. Male to female ratio in our study is 
12:1. The mean age of these patients were 50yrs. The mean age of 
patients with oropharyngeal carcinoma is 61yrs and that of 
nasopharyngeal carcinoma was 34yrs.  6 (23%) out of 26 patients 
received RT alone and 20 (77%) patients received the protocol concurrent 
chemo-radiation with weekly or 3 weekly CDDP and those with 
nasopharyngeal carcinoma also received the full course of adjuvant 
treatment with 3 weekly cisplatin and 5-FU. Out of the 16 patients with 
oropharyngeal carcinoma, 60% of the patients had base of tongue as their 
primary and 5% patients soft palate. 90% of the patients were found to be 
in locally advanced stage i.e. stage III and stage IVA and 3 (2 from 
oropharynx and 1 in Nasopharynx) patients were in early stage-II. All the 
characteristics of the patients and tumours are detailed in with pie charts.  
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Dose Volume Characteristics 
The mean doses and the volumes of these structures receiving 
specified doses are detailed in Table. The mean doses to the swallowing 
structures i.e. to the PC were kept at maximum mean dose of 56Gy, to the 
glottic and supraglottic larynx had maximum mean dose as 53Gy and the 
esophagus 59Gy. Out of the 26 patients in who optimized IMRT plans 
were executed and the V40, V50, V60 for all them were calculated. The   
mean doses to these structures co-related significantly with the volume of 
these structures within the PTV. The dysphagia optimized IMRT plans 
required up to 9 fields arrangement in order to achieve the required dose 
constraints. When executing the inverse plan, the requirement was to 
have a margin of a minimum of 5-7mm between the target volume 
delineation and the contour of the swallowing structures. According to 
our physicists at our center this was essential in order to achieve the 
required goal. And because of this additional margin that was required, 
the volume of these structures receiving 50Gy or more had considerably 
increased and this significantly reflected in the clinical outcome of the 
plan. Logically speaking, the patients with an advanced disease, bulky 
disease or nodes would invariably require a large target volume and in 
such cases defining the CTV plus a margin for the PTV greatly reduces 
the chance of keeping the volume of swallowing structures to a 
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minimum. The mean dose volume percentages of the structures are given 
in the table. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GSL Median 
Mean Dose (Gy) 47 
V40 (%) 82 
V50 (%) 52 
V60 (%) 44 
Esophagus  
Mean Dose (Gy) 45 
V40 (%) 51 
V50 (%) 50 
V60 (%) 16 
PC  
Mean Dose (Gy) 50 
V40 (%) 82 
V50 (%) 49 
V60 (%) 28 
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Field alignment of the optimized IMRT plan 
 
 
Topography of the field arrangement 
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Field alignment  
 
Dose colour wash in a Nasopharyngeal carcinoma patient 
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DVH of PC compared to the target volumes  
In this DVH, of a case of nasopharyngeal carcinoma, the volume of 
PC when compared to the target volumes is elicited. It clearly show that 
the volume of pharyngeal constrictors receiving the full prescribed dose 
i.e. 60Gy is kept at minimum where as about 60% of the volume receives 
50Gy or less. 
 
Yellow – PC, Green – GTV, Orange – CTV, Red – PTV 
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DVH of oropharyngeal carcinoma showing PC, GSL, ESOPHAGUS 
This is a case of locally advanced oropharyngeal carcinoma in 
which the V50 of the PC, GSL and Esophagus was 52%, 72%, and 30% 
respectively. Here, 100% of the volume of GSL and 99% of the volume 
of esophagus is receiving 40Gy. These dose volumes had significant co-
relation with patient reported dysphagia.  
 
Yellow – PC, Orange - GSL, Pink – Esophagus, Red – PTV60  
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DVH in a case of early stage oropharyngeal carcinoma 
In this case as it is an early stage disease, it was noted that there is 
considerable increase in the volume of swallowing structures being 
allowed to spare. The V60 of pharyngeal constrictors was only 8% with a 
mean dose of 43Gy and that of GSL, Esophagus was 11% and 0% 
respectively. Again such sparing has shown significant co-relation with 
the patient reported dysphagia. 
 
Yellow – PC, Orange - GSL, Pink – Esophagus, Red – PTV60  
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Another case of oropharyngeal carcinoma  
Mean dose: PC – 43Gy; GSL - 42Gy; Esophagus – 30Gy  
 
DVH in a case of Nasopharyngeal Carcinoma 
In both the cases presented below, the mean dose received by the 
constrictors was found to be 53-54Gy and the V50 and V60 was 
calculated to be 60-63% and 20-40% respectively. 
Yellow – PC, Orange - GSL, Pink – Esophagus, Red – PTV60  
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DVH in a case of locally advanced oropharynx with bulky node 
Yellow – PC, Orange - GSL, Pink – Esophagus, Red – PTV60  
 
 
DVH in a Case of Oropharynx 
Yellow – PC, Orange - GSL, Pink – Esophagus, Red – PTV60  
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Dose-Volume Effect Relationship at 3 months post therapy: 
The primary goal of this study was to reduce the volume of 
dysphagia related structures receiving more than 50Gy without any 
compromise in PTV. In each case, establishing a consensus for 
contouring and sparing the PC, GSL and esophagus was challenging. 
When the V60 of each of these cases was observed it was found that 
more the percentage of V60 to the constrictors, more the dysphagia. 
Significant co-relation was found with the constrictors and specifically 
the superior constrictors. In oropharyngeal carcinomas, when the disease 
was bulky or locally advanced, the feasibility of sparing the glottic and 
supra-glottic larynx without compromising the target volumes was 
difficult and accordingly the median of the mean dose to GSL in 
oropharynx was 51Gy when compared to median dose to GSL overall 
was only 47Gy. In a case of nasopharyngeal carcinoma, with respect the 
larynx the median of mean dose was 49Gy, which showed significant co-
relation in terms of the epiglottic function observed in the MBS.  2% of 
the patients in this study were found to be gastric tube dependent at the 
end of 3 months, 2 of the 26 patients aspirated when compared to nil 
patients prior to treatment. Aspiration patients consequently showed a 
mean dose of 53Gy and 54Gy to the GSL, which shows a significant co-
relation. Penetration was observed more in patients with oropharyngeal 
carcinoma i.e. 3 out of 16 patients. Among these patients, the mean dose 
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to the GSL was found to be around 49Gy. When co-related with patient 
reported dysphagia, it was found that in patients who had difficulty in 
swallowing liquids or the ones who were on liquid diet, the mean dose to 
the constrictors was 54Gy. These relationships between the volumes of 
dysphagia structures receiving a higher mean dose co-related 
significantly both clinically as well as statistically. When these results 
where compared to a retrospective study in which the DVH of the 
swallowing structures were co-related with patient reported dysphagia, 
there was a statistically significant difference both in DVH (PC – 
p=0.005, GSL – p=0.008, Esophagus – p=0.04) and incidence of 
dysphagia (p <0.001). 
 
Patient reported dysphagia – Subjective evaluation 
 Patient reported dysphagia was evaluated using the Head and Neck 
Quality of life (QOL) instrument and the University of Washington 
Quality of Life Questionnaire. As mentioned earlier, significant 
relationship was reported when the DVH of the different structures was 
compared to the patient related dysphagia. Out of the 26 patients, 2 
patients were gastric tube dependent, more than 85% of the patients did 
not have any reported dysphagia at the end of 3 months post treatment. 
Of the remaining 4 patients, 2 patients were swallowing solids with 
difficulty and 2 patients were on liquid diet.  Patients who were to gastric 
	   91	  
tube dependence, one of them was a case of advanced oropharyngeal 
carcinoma with mean dose to swallowing structures was around 48Gy-
49Gy and had residual disease. The other patient had maximum mean 
dose of 56Gy to the PC, 52Gy to GSL and 50Gy to esophagus. This co-
relation shows the clinical implication of using optimized IMRT plans 
and improving dysphagia. 
 
Direct Endoscopy Findings 
 Direct endoscopy is another measure of swallowing dysfunction. 
The anatomical aspect of dysfunction can be evaluated in this way. As a 
routine, for all patients endoscopy was done to evaluate the disease status.  
It was observed that out of 26 patients, 25 patients had complete 
remission at first follow up. At first follow up, 90% of the patients had 
complaints of dysphagia and anatomically in all the patients; it was found 
that the arytenoids were swollen. The complaint of dysphagia could be 
attributed to this finding. The patient reported dysphagia in such a case 
could be due to pain during swallowing which is interpreted as difficulty 
in swallowing by some patients. Such patients are more comfortable 
having soft solid diet and liquid diet which in turn dictates the quality of 
life of such patients.  
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Epiglottic thickening, decreased laryngeal movement, UES 
dysfunction due to fibrosis and edema also translate into factors causing 
aspiration and dysphagia. All these findings significantly co-relate with 
the percentage of these structures receiving the total prescribed dose in a 
way that the in patients with glottic dysfunction, the maximum dose to 
the GSL was found to be more than 55Gy and the same with epiglottis 
and arytenoids.  
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DISCUSSION 
In this study of an optimized IMRT strategy aiming at reducing the 
dose to dysphagia related structures (PC, GSL, Esophagus) we have 
found statistically significant and probably clinically important dose-
effect volume relationships for dysphagia and aspiration in such patients. 
These results thus achieved can serve as possible dosimetric goals for all 
patients being treated with IMRT. Avraham Eisbruch et.al (58) have 
hypothesized that reducing the dose to dysphagia and aspiration related 
structures might help improve dysphagia in patients being treated with 
the present day intense concurrent chemo-radiation regimens. The dose-
effect volume relationships achieved in this study support the hypothesis 
that by reducing the dose and the volume of the dysphagia related 
structures receiving target dose (i.e., volume of these structures coming 
within the PTV) can clinically improve treatment related dysphagia. The 
subsequent issue with such a hypothesis is that, such a study can support 
the hypothesis but will not able to prove it because we could not establish 
a cause - effect relationship. However it definitely establishes a need to 
try and further reduce the dose to these structures without compromising 
the PTV. The limiting factor in this is the percentage of volume of these 
structures, which come within the PTV, and this correlates strongly with 
the mean dose achieved for these structures. 
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The first step in achieving improved sparing of these structures by 
is avoiding setup errors by daily on board imaging and correction of these 
errors (78). The setup errors should be kept at as minimum as possible 
(i.e. 1 + 0.5mm).  Another valid way to accomplish this is to eliminate the 
PTVs and construction of IMRT plans that cover the CTVs and their 
known distribution of setup uncertainties. Other options including 
adaptive radiotherapy (or) proton beam IMRT (or) structure and target 
assessments.  
 
It was found that the dose volume effect relationships regarding 
aspiration could be related clinically the strongest in pharyngeal 
constrictors as a single organ including each of its parts, superior 
pharyngeal constrictor, middle pharyngeal constrictor and inferior 
constrictors. This relationship was statistically strongest for the superior 
pharyngeal constrictor. The importance of the superior constrictor 
regarding the dose volume effect relationship can be explained by the 
mechanism of swallowing. Elevation of larynx and pharynx and the 
closure of epiglottis are essential for airway protection as well as bolus 
propulsion. This mechanism is possible with the contraction of 
longitudinal muscles (glossopharyngeus,stylophayngeus,palatophayngeus 
and salpingopharyngeus) which blend with the circular muscles of the 
superior constrictor (79). As these muscles pull the pharynx and the 
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larynx upward and forward, away from the lower posterior pharyngeal 
wall which will allow the upper esophageal sphincter to open at the 
cricopharyngeus muscle (80). This mechanism of swallowing when 
correlated to the acquired objective results based on MBS of this study 
suggest that it is more beneficial to try and reduce the volume of superior 
constrictor receiving more than 50Gy than confining the constraint to the 
upper esophagus near the area of the inlet. The subjective results of this 
study also suggest the importance of sparing the superior constrictor 
when compared to middle and inferior constrictors. A recently conducted 
study in which brachytherapy was found to reduce dysphagia concluded 
that the doses to the superior and middle constrictors was the most 
significant predictors of patient-reported dysphagia (81). Significant dose 
volume effect correlations where found in GSL and dysphagia as well. A 
lot of recently conducted studies showed significant relationship between 
dysphagia and dose received by the glottic (82) and supraglottic larynx 
(82,83). Similar co-relations were found in our longitudinal study as well, 
in which the end-point comparison between pre and post-therapy 
dysphagia rather than dysphagia after radiation alone. This affirms that 
there is potential benefit in reducing the volume of glottic and 
supraglottic larynx receiving radiation therapy.  
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The dose volume effect relationships for the swallowing structures 
depend on the chemo-radiation regimen as well. In the present study, no 
strictures were found when mean dose received by the PC was <66Gy. In 
addition in another study it was found that after an intensive gemcitabine 
radiation regimen, the minimal dose associated with strictures was 
50Gy(56). Such differences in effect of intensity of dysphagia and 
aspiration based on chemo radiation regimens may be due to the intensity 
of acute mucositis and its effect on the pharyngeal tissue. Chemo-RT 
regimens, which do not differ in the intensity of acute mucositis seem to 
cause similar rate and types of swallowing abnormalities (59). 
 
In this study, the relative homogeneity of patient population, most 
of whom were oropharynx patients may have helped in identifying the 
dose effect relationship of the swallowing structures. Also, in this study 
we have observed dose volume relationships 3 months post therapy, and 
these relationships may change if observed over longer time duration   
(i.e. 6,12,24 months) post therapy. Swallowing seems to reach a steady 
state at around 12 months when edema subsides and long-term fibrosis 
sets in (84). The only way this issue could be addressed is that if we 
collect data for up to 24 months post therapy. Swallowing related 
pharyngeal and laryngeal motion may affect the dose delivered to these 
structures when compared to the simulation CTs. Studies based on of 
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these effects found that the incidence and duration of swallowing during 
RT is very low, averaging 0.45% (range, 0–1.5%) of the total irradiation 
time (85). In our study, the mean doses received by the swallowing 
structures were found to significantly correlate with the percentages of 
these structures within the PTVs. In a previous study, it was found that 
the percentages of these structures within the PTV did not change 
significantly with their expansion in order to produce planning organ-at-
risk volumes was made, when compared with the non-expanded 
structures (58). Such data suggests that when the swallowing structures 
are expanded in order to obtain their respective organ-at-risk volumes 
will not substantially change the planning, optimization and results of our 
study. This issue has to be investigated further. As detailed earlier in the 
material and methods, we have taken only the lateral RP nodes into 
consideration not the medial ones for the nodal CTVs only when RP 
nodes were considered to be of high risk (unless the lateral RP nodes 
were grossly involved). This method felicitated the possibility of partial 
sparing of the PC and the upper part of GSL. Several RP nodal failures 
have been reported in patients being treated with IMRT and most of them 
were found to be in the lateral RP space, medial to the carotid artery (61). 
McLaughlin et al. (63) stated that the medial RP nodes have not often 
been recognized as sites of cancer metastases. The literature search found 
several series of head-and-neck cancer that detailed involvement of the 
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lateral and medial RP nodes (63–73). These series showed a very low risk 
of medial RP nodal involvement; in 10 series a cumulative report of 
about 600 patients with RP nodal involvement or enlargement showed 
that 98% of the patients showed lateral RP nodal involvement and 2% 
showed medial RP nodes. One of these series detailed the results of 
dissection of 11 cadavers and 9 of them showed lateral RP nodes (73). In 
our study, the afferent lymphatics from Nasopharynx and Oropharynx 
were found to be flowing into the lateral RP nodes whereas the medial 
nodes received lymphatics from the posterior pharyngeal wall. These 
series suggest that in almost all cases in which the RP nodes are at risk 
show that lateral RP nodes are at substantial risk of involvement (except 
for the posterior pharyngeal wall tumours). However the actual 
consequence of under dosing the medial RP nodes is not yet clearly 
known as the lymphatic channels transverse through the medial RP space. 
The under dosing becomes an issue because sparing of the swallowing 
structures results in steeper dose fall-off near the targets in the vicinity of 
these structures (58), compared with IMRT plans that do not include such 
modified IMRT plans. Therefore, outlining the targets requires a high 
level of precaution so that the target volumes do not get compromised or 
under dosed taking into account the uncertainty of defining the mucosal 
gross tumour volume using the available imaging modalities (86). This 
forms the basis for our optimized IMRT plan for this study, i.e., not to 
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compromise the target volume under any circumstances. Thus, so far in 
this study within a median follow up of about 12 months, only two 
failures have occurred and the failure was within the previously 
prescribed GTV, which were given the full-prescribed dose.  
 
 
 
The prescribed IMRT plan in our study included the whole neck. 
Another approach to this is to include the plan for the primary and upper 
neck and to match the same with a low anterior neck field at the thyroid 
notch with a midline laryngeal block. This results in lower doses to the 
GSL (87,88) but the issue with such an approach is that in cases, which 
have a high risk of posterior deep neck nodal involvement, cases might 
	   100	  
result in under-dosing of these deep lying targets. This might be a reason 
for some reported lower neck failures (89,90).   
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CONCLUSION 
We can conclude that sparing the swallowing structures using 
optimized IMRT, is feasible. It was found that the relationship between 
the dose volume values for the swallowing structures and the objective 
and subjective measures of dysphagia was statistically significant and 
clinically relevant. In an attempt to obtain such goals, it is very important 
not to forget the importance of avoiding missing or under dosing the 
target volumes. These thus found relationships could now be used to 
prescribe optimized goals and thus push forward more efforts in order to 
reduce the dose to these structures further. This also improves the QOL of 
these patients and serves the purpose of organ and function preservation 
when chemo-radiation is used as the treatment modality rather than 
surgery. There is a need to observe long-term results in order to obtain 
stronger results in terms of disease recurrence or survival.  
In terms of statistical significance of this study, it is recommended 
to try and reduce the dose to the swallowing structures. The question is 
whether it is a possibility in terms of availability of expertise, time 
consumption and logistics in a country like India. Cost vs benefit 
analyses of such a study is something that can be considered. 
Implementation of such a strategy using IMRT technique helps to 
improve QOL of head and neck cancer patients but the feasibility of such 
a study in an Indian scenario is questionable.  
